Write in a clean editor, then format for Chinese Medical Journal - Pulmonary and Critical Care Medicine in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Chinese Medical Journal - Pulmonary and Critical Care Medicine is a peer-reviewed journal published by Elsevier, covering Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases, Lung Cancer Treatments and Mutations.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Chinese Medical Journal - Pulmonary and Critical Care Medicine 12 (2023) 45–58.
Formats any DOI in Chinese Medical Journal - Pulmonary and Critical Care Medicine style. No sign-up. |
| Publishes research in | Chronic Obstructive Pulmonary Disease (COPD) Research Asthma and respiratory diseases Lung Cancer Treatments and Mutations Lung Cancer Research Studies Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis |
| ISSN | 2772-5588 |
| Citation impact (2-yr) | 7.34 |
| h-index | 19 |
| i10-index | 46 |
| Total citations | 1,162 |
| Top institutions publishing here | Chinese Academy of Medical Sciences & Peking Union Medical College |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Endothelial cells (ECs) form a semi-permeable barrier between the interior space of blood vessels and the underlying tissues. Pulmonary endothelial barrier integrity is maintained through coordinated cellular processes involving receptors, signaling molecules, junctional complexes, and protein-regulated cytoskeletal reorganization. In acute lung injury (ALI) or its more severe form acute respiratory distress syndrome (ARDS), the loss…
The coronavirus disease 2019 (COVID-19) pandemic has been ongoing for more than 3 years, with an enormous impact on global health and economies. In some patients, symptoms and signs may remain after recovery from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which cannot be explained by an alternate diagnosis; this condition has been defined…
The pandemic of coronavirus disease 2019 (COVID‑19), caused by a novel severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), has caused an enormous impact on the global healthcare. SARS-CoV-2 infection primarily targets the respiratory system. Although most individuals testing positive for SARS-CoV-2 present mild or no upper respiratory tract symptoms, patients with severe COVID-19 can…
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive interstitial lung disease with a dismal prognosis. Early diagnosis, accurate prognosis, and personalized therapeutic interventions are essential for improving patient outcomes. Biomarkers, as measurable indicators of biological processes or disease states, hold significant promise in IPF management. In recent years, there has been a growing interest…
Background: The aim of this review is to summarize the current evidence regarding small airway disease in asthma, focusing on recent advances in small airway pathophysiology, assessment and therapeutic implications. Methods: A search in Medline was performed, using the keywords "small airways", "asthma", "oscillometry", "nitrogen washout" and "imaging". Our review was based on studies from…
